Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.

Jianan HaoYichao WangLijing HuoTiantian SunYunfeng ZhenZhe GaoShuchun ChenLuping Ren

Published in: International journal of general medicine (2022)

Serum BMP-9 levels are significantly lower in the T2DM+NAFLD group when compared to other groups, and BMP-9 is an independent risk factor for T2DM paired with NAFLD.

Keyphrases

mesenchymal stem cells
bone regeneration
glycemic control
liver fibrosis
metabolic syndrome